STOCK TITAN

Abrdn Life Sciences Investors - $HQL STOCK NEWS

Welcome to our dedicated page for Abrdn Life Sciences Investors news (Ticker: $HQL), a resource for investors and traders seeking the latest updates and insights on Abrdn Life Sciences Investors stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Abrdn Life Sciences Investors's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Abrdn Life Sciences Investors's position in the market.

Rhea-AI Summary
abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) have announced an increase in distribution rates approved by their respective Boards of Trustees. HQH and HQL will see a 25% increase from 8% to 10% in their managed distribution policy, while THQ will experience a 60% increase in its stable distribution policy. The distributions will be made from net investment income, net realized capital gains, and return of capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Tekla Life Sciences Investors (NYSE: HQL) Declares $0.32 Per Share Distribution
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
Rhea-AI Summary
Tekla Life Sciences Investors has declared a distribution of $0.32 per share. The distribution will be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash. Shareholders may request to be paid in cash instead of shares. Tekla Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
buyback
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
buyback
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
Abrdn Life Sciences Investors

NYSE:HQL

HQL Rankings

HQL Stock Data

377.98M
27.35M
0.01%
33.91%
0.08%
Securities and Commodity Exchanges
Finance and Insurance
Link
United States of America
Boston